Transforming growth factor-β in critical illness

Critical Care Medicine

Volumn 33, Issue 12 SUPPL., 2005, Pages

  Zamora, Ruben ^a   Vodovotz, Yoram ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

CELL TYPE; CRITICAL ILLNESS; DRUG TARGETING; HISTORY OF MEDICINE; HUMAN; INFLAMMATION; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

EID: 28944446130     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000191725.59611.14     Document Type: Article

References (49)

1. Roberts AB, Sporn MB: The transforming growth factor-βs. In: Peptide Growth Factors and Their Receptors. Sporn MB, Roberts AB (Eds). Berlin, Springer-Verlag, 1990, pp 419-472
2. Kulkarni AB, Thyagarajan T, Letterio JJ: Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2002; 2:303-327
3. Wahl SM: TGF-beta in the evolution and resolution of inflammatory and immune processes: Introduction. Microbes Infect 1999; 1:1247-1249
4. Unsicker K, Strelau J: Functions of transforming growth factor-beta isoforms in the nervous system: Cues based on localization and experimental in vitro and in vivo evidence. Eur J Biochem 2000; 267:6972-6975
5. Annes JP, Munger JS, Rifkin DB: Making sense of latent TGFbeta activation. J Cell Sci 2003; 116:217-224
6. Massagué J: The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6:597-641
7. Barcellos-Hoff MH, Dix TA: Redox mediated activation of latent transforming growth factor-β1. Mol Endocrinol 1996; 10:1077-1083
8. Vodovotz Y, Chesler L, Chong H, et al: Regulation of transforming growth factor-β1 by nitric oxide. Cancer Res 1999; 59:2142-2149
9. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700
10. Ten Dijke P, Hill CS: New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004; 29:265-273
11. Roberts AB, Anzano MA, Lamb LC, et al: New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Nat Acad Sci U S A 1981; 78:5339-5343
12. Letterio JJ, Vodovotz Y, Bogdan C: TGF-β and IL-10: Inhibitory cytokines regulating immunity and the response to infection. In: Novel Cytokine Inhibitors. Henderson B, Higgs G (Eds). Basel, Birkhauser Verlag, 2000, pp 217-242
13. Barnard JA, Bascom CC, Lyons RM, et al: Transforming growth factor beta in the control of epidermal proliferation. Am J Med Sci 1988; 296:159-163
14. Akhurst RJ, Lehnert SA, Gatherer D, et al: The role of TGF beta in mouse development. Ann N Y Acad Sci 1990; 593:259-271
15. Roberts AB, Flanders KC, Heine UI, et al: Transforming growth factor-beta: Multifunctional regulator of differentiation and development. Philos Trans R Soc Lond B Biol Sci 1990; 327:145-154
16. Limper AH: Detection of TGF-beta in body fluids and tissues. Methods Mol Biol 2000; 142:39-54
17. Tucker RF, Shipley GD, Moses HL, et al: Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 1984; 226:705-707
18. Ruegemer JJ, Ho SN, Augustine JA, et al: Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression. J Immunol 1990; 144:1767-1776
19. Abe M, Harpel JG, Metz CN, et al: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994; 216:276-284
20. Danielpour D, Dart LL, Flanders KC, et al: Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Phys 1989; 138:79-86
21. Flanders KC, Thompson NL, Cissel DS, et al: Transforming growth factor-beta 1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989; 108:653-660
22. Barcellos-Hoff MH: Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 1993; 53:3880-3886
23. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, et al: Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 1995; 147:1228-1237
24. Chong H, Vodovotz Y, Cox GW, et al: Immunocytochemical detection of latent TGF-β activation in cultured macrophages. J Cell Physiol 1999; 178:275-283
25. Torre D, Tambini R, Aristodemo S, et al: Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. Mediators Inflamm 2000; 9:193-195
26. Sfeir T, Saha DC, Astiz M, et al: Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 2001; 29:129-133
27. Ehrhart EJ, Carroll A, Segarini P, et al: Latent transforming growth factor-β activation in situ: Quantitative and functional evidence following low dose irradiation. FASEB J 1997; 11:991-1002
28. Perrella MA, Hsieh CM, Lee WS, et al: Arrest of endotoxin-induced hypotension by transforming growth factor beta1. Proc Nat Acad Sci U S A 1996; 93:2054-2059
29. Laun RA, Schroder O, Schoppnies M, et al: Transforming growth factor-beta1 and major trauma: Time-dependent association with hepatic and renal insufficiency. Shock 2003; 19:16-23
30. Nathan C, Sporn M: Cytokines in context. J Cell Biol 1991; 113:981
31. Vodovotz Y, Clermont G, Chow C, et al: Mathematical models of the acute inflammatory response. Curr Opin Crit Care 2004; 10:383-390
32. Clermont G, Bartels J, Kumar R, et al: In silico design of clinical trials: A method coming of age. Crit Care Med 2004; 32:2061-2070
33. Ayala A, Knotts JB, Ertel W, et al: Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg 1993; 128:89-94
34. Hamon G, Mulloy RH, Chen G, et al: Transforming growth factor-beta 1 lowers the CD14 content of monocytes. J Surg Res 1994; 57:574-578
35. Ahmad S, Choudhry MA, Shankar R, et al: Transforming growth factor-beta negatively modulates T-cell responses in sepsis. FEBS Lett 1997; 402:213-218
36. Vodovotz Y, Kopp JB, Takeguchi H, et al: Increased mortality, blunted production of nitric oxide, and increased production of TNF-alpha in endotoxemic TGF-beta1 transgenic mice. J Leukoc Biol 1998; 63:31-39
37. Pellacani A, Wiesel P, Sharma A, et al: Induction of heme oxygenase-1 during endotoxemia is downregulated by transforming growth factor-beta1. Circ Res 1998; 83:396-403
38. Pellacani A, Wiesel P, Razavi S, et al: Downregulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta1. J Biol Chem 2001; 276:1653-1659
39. Havlir DV, Torriani FJ, Schrier RD, et al: Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol 2001; 39:298-303
40. Yin M, Bradford BU, Wheeler MD, et al: Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001; 166:4737-4742
41. Varedi M, Jeschke MG, Englander EW, et al: Serum TGF-beta in thermally injured rats. Shock 2001; 16:380-382
42. Rumbaugh KP, Colmer JA, Griswold JA, et al: The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response. Cytokine 2001; 16:160-168
43. Oku H, Nakazato H, Horikawa T, et al: Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock. Eur J Pharmacol 2002; 446:167-176
44. Yeh FL, Shen HD, Fang RH: Deficient transforming growth factor beta and interleukin-10 responses contribute to the septic death of burned patients. Burns 2002; 28:631-637
45. Malaguarnera L, Pignatelli S, Simpore J, et al: Plasma levels of interleukin-12 (IL-12), interleukin-18 (IL-18) and transforming growth factor beta (TGF-beta) in Plasmodium falciparum malaria. Eur Cytokine Netw 2002; 13:425-430
46. Omer FM, de Souza JB, Riley EM: Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J Immunol 2003; 171:5430-5436
47. Ling E, Feldman G, Dagan R, et al: Cytokine mRNA expression in pneumococcal carriage, pneumonia, and sepsis in young mice. J Infect Dis 2003; 188:1752-1756
48. Lekkou A, Karakantza M, Mouzaki A, et al: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11:161-167
49. Hallatschek W, Fiedler G, Kirschning CJ, et al: Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur J Immunol 2004; 34:1441-1450